This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davies, E. Articles by Clauser, E. Search for Related Content PubMed PubMed Citation Articles by Davies, E. Articles by Clauser, E.

Somatic Mutations of the Angiotensin II (AT₁) Receptor Gene are Not Present in Aldosterone-Producing Adenoma¹

INSERM U-36, Collège de France, Paris, France

Address all correspondence and requests for reprints to: Dr. Eric Clauser, INSERM U-36, Collège de France, 3 rue d’Ulm, 75005 Paris, France.

Angiotensin II stimulates aldosterone secretion from the adrenal zona glomerulosa and mediates most of its biological effects via G protein-coupled type 1 angiotensin II receptors (AT₁). A number of G protein-coupled receptors are constitutively activated as a result of somatic mutations in the gene encoding the protein. It is, therefore, possible that primary hyperaldosteronism caused by an aldosterone-producing adenoma (APA) may be the result of constitutive activation of the AT₁ receptor. The 1.1-kilobase coding region (exon 5) of the AT₁ receptor gene was analyzed in APA and normal adrenal tissue for the presence of mutations using single stranded conformational polymorphism and sequencing techniques. In 17 APAs, no functional mutations were found that could account for the observed pathophysiology. However, three silent polymorphisms were detected in regions encoding the second extracellular loop, the intracellular arm preceding the COOH terminal, and the 3'-untranslated region. In conclusion, somatic mutations in the coding region of the AT₁ receptor gene do not appear to play a role in primary hyperaldosteronism caused by an APA.

This article has been cited by other articles:

				H.-W. Chang, T.-S. Chu, H.-Y. Huang, S.-C. Chueh, V.-C. Wu, Y.-M. Chen, B.-S. Hsieh, and K.-D. Wu Down-Regulation of D2 Dopamine Receptor and Increased Protein Kinase C{micro} Phosphorylation in Aldosterone-Producing Adenoma Play Roles in Aldosterone Overproduction J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1863 - 1870. [Abstract] [Full Text] [PDF]

				S. Billet, S. Bardin, R. Tacine, E. Clauser, and S. Conchon The AT1A receptor "gain-of-function" mutant N111S/{Delta}329 is both constitutively active and hyperreactive to angiotensin II Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E840 - E848. [Abstract] [Full Text] [PDF]

				P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF]

				C. A. Koch, K. Pacak, and G. P. Chrousos The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary Tumors J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5367 - 5384. [Abstract] [Full Text] [PDF]

				D. J. Torpy, R. D. Gordon, J. P. Lin, P. R. Huggard, S. E. Taymans, M. Stowasser, G. P. Chrousos, and C. A. Stratakis Familial Hyperaldosteronism Type II: Description of a Large Kindred and Exclusion of the Aldosterone Synthase (CYP11B2) Gene J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3214 - 3218. [Abstract] [Full Text]

				D. J. Torpy and C. A. Stratakis Linkage Analysis of Familial Hyperaldosteronism Type II--Absence of Linkage to the Gene Encoding the Angiotensin II Receptor Type 1 J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 1046 - 1046. [Full Text]

				C. Parnot, S. Bardin, S. Miserey-Lenkei, D. Guedin, P. Corvol, and E. Clauser Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay PNAS, June 20, 2000; 97(13): 7615 - 7620. [Abstract] [Full Text] [PDF]